US 6509363
Heterocyclic inhibitors of p38
expired A61PA61P19/00A61P25/00
Quick answer
US patent 6509363 (Heterocyclic inhibitors of p38) held by Vertex Pharmaceuticals Incorporated expires Mon Jan 16 2023 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue Jan 21 2003 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 16 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 32
- CPC classes
- A61P, A61P19/00, A61P25/00, A61P25/04, A61P29/00